18 May 2013
Keywords: roche, pegasys, filed, hepatitis, swiss, drug, major
Article | 26 July 2004
Swiss drug major Roche has submitted a supplemental Biologics LicenseApplication to the US Food and Drug Administration for the use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2004
27 September 2004
17 May 2013
© 2013 thepharmaletter.com